LON:VEC - Vectura Group Share Price, Forecast & News

Vectura Group trades on the London Stock Exchange (LON) under the ticker symbol "VEC."

Vectura Group declared a dividend on Tuesday, September 10th. Stockholders of record on Monday, October 14th will be given a dividend of GBX 6 per share on Friday, October 25th. The ex-dividend date of this dividend is Monday, October 14th. The official announcement can be viewed at this link. View Vectura Group's Dividend History.

Vectura Group is scheduled to release their next quarterly earnings announcement on Tuesday, March 17th 2020. View Earnings Estimates for Vectura Group.

6 equities research analysts have issued 1 year price targets for Vectura Group's shares. Their forecasts range from GBX 114 to GBX 160. On average, they expect Vectura Group's share price to reach GBX 138.50 in the next twelve months. This suggests a possible upside of 57.9% from the stock's current price. View Analyst Price Targets for Vectura Group.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vectura Group in the last year. There are currently 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Vectura Group.

News articles about VEC stock have trended extremely negative this week, InfoTrie Sentiment reports. The research firm rates the sentiment of press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Vectura Group earned a media sentiment score of -4.6 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Vectura Group.

Some companies that are related to Vectura Group include Opthea (OPT), Medical Developments International (MVP), Mayne Pharma Group (MYX), BEXIMCO PHARMAC/S GDR REGS (BXP), Eco Animal Health Group (EAH), Trilogy International Partners (TRL), Allergy Therapeutics (AGY), NanoViricides (NNVC), Recce Pharmaceuticals (RCE), Vita Life Sciences (VLS), Pharmaxis (PXS), Avivagen (VIV), Futura Medical (FUM), Patrys (PAB) and Antisense Therapeutics (ANP).

Based on aggregate information from My MarketBeat watchlists, some companies that other Vectura Group investors own include Hikma Pharmaceuticals (HIK), SkyePharma (SKP), BTG (BTG), SINR PHAR/PAR VTG FPD 0.01 (SPH), iRobot (IRBT), Sirius Minerals (SXX), Coats Group (COA), Griffin Mining (GFM), HSBC (HSBA) and Inmarsat (ISAT).

Shares of VEC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

One share of VEC stock can currently be purchased for approximately GBX 87.70.

Vectura Group has a market capitalization of £533.49 million and generates £172.30 million in revenue each year. Vectura Group employs 478 workers across the globe.View Additional Information About Vectura Group.

The official website for Vectura Group is http://www.vectura.com/.

Vectura Group's mailing address is One Prospect West, CHIPPENHAM, SN14 6FH, United Kingdom. The company can be reached via phone at +44-1249-667700.